Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
China Resources Double-Crane Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥17.42 |
52 Week High | CN¥24.13 |
52 Week Low | CN¥14.80 |
Beta | 0.064 |
11 Month Change | -18.48% |
3 Month Change | -15.11% |
1 Year Change | 4.19% |
33 Year Change | 52.94% |
5 Year Change | 38.47% |
Change since IPO | 511.93% |
Recent News & Updates
Recent updates
We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease
Jul 16China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 24Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel
Mar 02Shareholder Returns
600062 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -4.7% | 1.1% | 2.2% |
1Y | 4.2% | -16.2% | -18.6% |
Return vs Industry: 600062 exceeded the CN Pharmaceuticals industry which returned -16.2% over the past year.
Return vs Market: 600062 exceeded the CN Market which returned -18.6% over the past year.
Price Volatility
600062 volatility | |
---|---|
600062 Average Weekly Movement | 4.0% |
Pharmaceuticals Industry Average Movement | 5.7% |
Market Average Movement | 6.5% |
10% most volatile stocks in CN Market | 9.8% |
10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600062's share price has been volatile over the past 3 months.
Volatility Over Time: 600062's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1939 | 12,269 | n/a | www.dcpc.com |
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other.
China Resources Double-Crane Pharmaceutical Co.,Ltd. Fundamentals Summary
600062 fundamental statistics | |
---|---|
Market cap | CN¥17.95b |
Earnings (TTM) | CN¥1.37b |
Revenue (TTM) | CN¥10.28b |
12.9x
P/E Ratio1.7x
P/S RatioIs 600062 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600062 income statement (TTM) | |
---|---|
Revenue | CN¥10.28b |
Cost of Revenue | CN¥4.60b |
Gross Profit | CN¥5.68b |
Other Expenses | CN¥4.31b |
Earnings | CN¥1.37b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
Earnings per share (EPS) | 1.35 |
Gross Margin | 55.24% |
Net Profit Margin | 13.36% |
Debt/Equity Ratio | 2.1% |
How did 600062 perform over the long term?
See historical performance and comparison